Table 3. Score, rank and inter-class correlation of point-of-care technologies assessed with the scorecard.
Analyzer Category | Product | Average Score (Range) | Mean Rank | p-value | Percent of Top Score in Category | Intra-class correlation* |
CD4 T+ cell count | 1 | 4.00 (3.83–4.08) | 1 | p = 0.125 | 100.0% | 0.862 (0.777–0.924) |
2 | 3.06 (2.82–3.16) | 2 | 76.4% | 0.845 (0.755–0.916) | ||
Multiple-parameter clinical chemistry | 1 | 3.89 (3.79–4.04) | 1 | p = 0.01 | 100.0% | 0.865 (0.782–0.926) |
2 | 3.56 (3.46–3.66) | 2 | 91.4% | 0.927 (0.879–0.961) | ||
3 | 3.33 (3.29–3.43) | 3.25 | 85.7% | 0.852 (0.762–0.918) | ||
4 | 3.26 (3.14–3.44) | 3.75 | 83.8% | 0.873 (0.794–0.931) | ||
5 | 3.07 (2.99–3.23) | 5 | 78.8% | 0.921 (0.868–0.958) | ||
6 | 2.78 (2.65–2.88) | 6 | 71.4% | 0.959 (0.931–0.978) | ||
Limited-parameter clinical chemistry | 1 | 4.15 (3.98–4.40) | 1 | p = 0.001 | 100.0% | 0.864 (0.776–0.926) |
2 | 4.10 (3.96–4.30) | 2 | 98.8% | 0.881 (0.805–0.935) | ||
3 | 3.89 (3.76–3.96) | 3.25 | 93.7% | 0.955 (0.924–0.976) | ||
4 | 3.39 (3.18–3.76) | 3.75 | 81.8% | 0.834 (0.735–0.908) | ||
Multiple-parameter hematology | 1 | 3.75 (3.56–3.94) | 1 | p = 0.069 | 100.0% | 0.855 (0.767–0.920) |
2 | 3.73 (3.58–3.84) | 2.5 | 99.5% | 0.979 (0.683–0.886) | ||
3 | 2.96 (2.66–3.12) | 2.5 | 79.1% | 0.837 (0.738–0.909) | ||
Limited-parameter hematology | 1 | 4.17 (4.01–4.40) | 1 | p = 0.001 | 100.0% | 0.974 (0.955–0.986) |
2 | 3.75 (3.61–3.88) | 2 | 90.0% | 0.905 (0.844–0.949) | ||
3 | 3.62 (3.55–3.70) | 1.25 | 86.8% | 0.972 (0.952–0.985) | ||
4 | 3.57 (3.46–3.64) | 1.75 | 85.6% | 0.802 (0.688–0.888) |
all p-values<0.0001.